Pharma

Your Article Summary

See Latest Articles

CorMatrix Announces Pre-Clinical Data Suggesting Next Generation ECM Technology Can Improve Cardiac Function
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/12/08

CorMatrix Cardiovascular, Inc., an Atlanta-based company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, presented data demonstrating that an injection of an emulsified version of their ECM Technology improved cardiac function.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology